Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2012
11/01/2012CA2834365A1 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
11/01/2012CA2834355A1 Methods and compositions using pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
11/01/2012CA2834353A1 Liposomal vancomycin for the treatment of mrsa infections
11/01/2012CA2834286A1 Methods of treating alzheimer's disease, huntington's disease, autism, and other disorders
11/01/2012CA2834255A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012CA2834136A1 Anti-b7-h3 antibody
11/01/2012CA2834040A1 Intravascular delivery of nanoparticle compositions and uses thereof
11/01/2012CA2833592A1 Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-fu) and irinocetan (folfiri)
11/01/2012CA2833500A1 Lyophilized preparation of cytotoxic dipeptides
11/01/2012CA2833206A1 Intermediate for synthesizing caspofungin and preparation method therefor
11/01/2012CA2830659A1 Hemostatic compositions
10/2012
10/31/2012EP2518496A2 BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
10/31/2012EP2518149A1 HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
10/31/2012EP2518142A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
10/31/2012EP2517722A2 Treatment of T-cell mediated diseases
10/31/2012EP2517721A2 Treatment of T-cell mediated diseases
10/31/2012EP2517720A1 Stabilized therapeutic small helical antiviral peptides
10/31/2012EP2517719A1 Treatment of T-cell mediated diseases
10/31/2012EP2517718A2 Treatment of T-cell mediated diseases
10/31/2012EP2517710A1 Tamper-resistant oral opioid agonist formulations
10/31/2012EP2517699A1 Composition for prevention and treatment of arthritis
10/31/2012EP2517003A1 Secreted protein acidic and rich in cysteine (sparc) protein srm/mrm assay
10/31/2012EP2517002A1 Insulin receptor substrate 1 (irs1) protein srm/mrm assay
10/31/2012EP2516646A2 Method of treatment and screening method
10/31/2012EP2516629A2 Herpes simplex virus vaccines
10/31/2012EP2516508A2 Amphiphilic polymer functionalised by methionine
10/31/2012EP2516458A1 Tetravalent cd47-antibody constant region fusion protein for use in therapy
10/31/2012EP2516456A1 Bmp-7 variants with reduced immunogenicity
10/31/2012EP2516452A1 Mutant nisin ser 29 derivatives and the use thereof
10/31/2012EP2515932A2 Synergic action of a prolyl protease and tripeptidyl proteases
10/31/2012EP2515931A1 Compositions comprising boosting polypeptide and starch degrading enzyme and uses thereof
10/31/2012EP2515930A1 Methods and compositions related to reduced met phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells
10/31/2012EP2515929A1 Methods and use related to humanin and humanin-like peptides
10/31/2012EP2515928A1 Oxyntomodulin peptide analogue
10/31/2012EP2515927A1 Oxyntomodulin peptide analogue
10/31/2012EP2515926A1 Compositions and methods for the treatment of angiogenesis-related eye diseases
10/31/2012EP2515919A2 Methods of using small compounds to enhance myeloid derived suppressor cell function for treating autoimmune diseases
10/31/2012EP2515901A2 Compositions and methods for treating obesity and diabetes
10/31/2012EP2515878A2 Sustained-release formulation
10/31/2012EP2515870A2 Topical ophthalmic peptide formulation
10/31/2012EP2515868A1 Pharmaceutical compositions comprising igf-1 proteins, a buffering and a tonicity agent
10/31/2012CN1939532B Use of fungal immunomodulatory protein
10/31/2012CN1612750B TACI-immunoglobulin fusion proteins
10/31/2012CN102762591A Fibronectin based scaffold domain proteins that bind il-23
10/31/2012CN102762589A Insulin analogues with chlorinated amino acids
10/31/2012CN102762586A Therapeutic peptides
10/31/2012CN102762223A Ev576 for use in the treatment of viral infections of the respiratory tract
10/31/2012CN102762222A Compositions and methods comprising protease variants
10/31/2012CN102762221A Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
10/31/2012CN102762220A Human anti-amyloid antibodies, compositions,methods and uses
10/31/2012CN102757948A Haemocoagulase agkistrodon and separation method thereof
10/31/2012CN102757945A Human urate oxidase protein and preparation method and polyethylene glycol composite thereof
10/31/2012CN102757938A Application of VSTM1 protein in preparation of product for promoting differentiation of leukemic cells
10/31/2012CN102757564A Preparation method and application of tree-like polyester-polyglycidol block polymer
10/31/2012CN102757503A Preparation method and application of human prostate apoptosis response protein 4 and apoptin 2 ligand fusion protein
10/31/2012CN102757500A Pegylation modifier of long-acting thymosin alpha1
10/31/2012CN102757482A Polypeptide and application thereof
10/31/2012CN102757478A Allyl cysteinyl amino acid derivative and synthesis method and application thereof
10/31/2012CN102757477A Allyl cysteinyl amino acid methyl ester derivative and synthesis method and application thereof
10/31/2012CN102757476A Preparation method and application of squid ink peptidoglycan
10/31/2012CN102755669A Preparation method and application of fibrin glue composite recombinant human bone morphogenetic protein-2 (rhBMP-2) microsphere
10/31/2012CN102755649A Pharmaceutical composition and related methods
10/31/2012CN102755641A Application of chymotrypsin preparation in treating oral ulcer
10/31/2012CN102755640A Plant chinese herbal medicine essence complex disinfectant
10/31/2012CN102755639A Medicine for removing chorioplaque
10/31/2012CN102755638A Application of AGGF1 in preparing medicines for promoting angiogenesis
10/31/2012CN102755637A Composition for preventing and treating ischemia reperfusion injury
10/31/2012CN102755636A Application of bFGF (basic Fibroblast Growth Factor) to preparation of medicament for treating human ischemic stroke
10/31/2012CN102755635A Composition for improving gastrointestinal function and preparation method thereof
10/31/2012CN102755634A Nutrient composition
10/31/2012CN102755633A Application of human recombinant protein PDCD5 to treatment of autoimmune disease
10/31/2012CN102755632A Secretory protein related to cell viability and coding gene and application of secretory protein related to cell viability
10/31/2012CN102755631A Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/31/2012CN102755630A Application of oral needle mushroom immunoregulation protein to prevention and treatment of allergic asthma
10/31/2012CN102755629A Component for forming bacterium-resisting and efficacy-enhancing inclusion compound together with vancomycin and preparation method and application thereof
10/31/2012CN102755628A Antifungal pharmaceutical composition
10/31/2012CN102755627A Method for preparing goserelin slow-release implant
10/31/2012CN102755523A Serine peptidase chrome chelating agent for anti-oxidation and anti-fatigue and preparation method thereof
10/31/2012CN102755289A Argatroban injection for resisting thrombus and preparation method thereof
10/31/2012CN102754668A Novel Chinese herbal medicine compound disinfectant solution
10/31/2012CN102077928B Tilapia immune potentiator and preparation method thereof
10/31/2012CN101785854B Lutein multivitamin nutrition health care medicine composition and preparation method and applications thereof
10/31/2012CN101757616B Safe freeze-dried mammal thrombin preparation and preparation method thereof
10/31/2012CN101736065B Method for preparing polypeptide by beer sediment
10/31/2012CN101573130B Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy
10/31/2012CN101538311B Alpha-amido acyl-ring imide peptoid metalloprotease inhibitor and application thereof
10/31/2012CN101516388B Glycosylation of peptides via O-linked glycosylation sequences
10/31/2012CN101455405B Food or medicine capable of promoting wound healing after operation
10/31/2012CN101234193B Stable water solution containing recombination human serum albumin fusion interferon
10/30/2012US8299215 Methods and compositions for treating brain diseases
10/30/2012US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
10/30/2012US8299212 TDF-related compounds and analogs thereof, analogs and bioactive fragments
10/30/2012US8299211 Peptides and regulation of calcium channels
10/30/2012US8299209 Pharmaceutical composition comprising cyclic somatostatin analogues
10/30/2012US8299129 Peptide lipid-containing carrier and method for introducing compound into cells using same
10/30/2012US8299094 Hepatitis C virus inhibitors
10/30/2012US8299044 Apoptosis inducer for cancer cell
10/30/2012US8299032 Self-assembling peptide and gel produced from the same
10/30/2012US8299031 Human semen enhancer of viral infection peptides (SEVI) and their use
10/30/2012US8299030 Peptide-based compounds
1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 3163